MEDIPURE SCANDINAVIA A/S: Financial statements 2018
CVR: 13275149
Source: annual report 2018, Danish Business Authority
01/07/2017 – 30/06/2018
MEDIPURE SCANDINAVIA A/S (CVR 13275149) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -66,091 and a net result of DKK -112,495 compared with DKK 158,230 the year before. Equity in the 2018 report amounted to DKK 1,641,492. The solvency ratio was 98.7%.
- Gross Profit
- DKK -66,091
- Profit/Loss
- DKK -112,495
- Equity
- DKK 1,641,492
- Total Assets
- DKK 1,662,687
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -66K | -112K | 1.6M | - |
| 2017 | - | 269K | 158K | 1.8M | - |
| 2016 | - | 89K | 90K | 1.6M | - |
| 2015 | - | 95K | 170K | 1.5M | - |
| 2014 | - | 582K | 592K | 1.9M | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationAbout MEDIPURE SCANDINAVIA A/S
MEDIPURE SCANDINAVIA A/S was a Danish company of the type Aktieselskab based in Risskov, founded in 1989. The company has been dissolved on 12 November 2025. The company was registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named BAXA INTERNATIONAL ApS and ASX 14709 ApS. The company has 1 employee (2009). In 2024, the company reported a gross profit of DKK -24,760 and a net result of DKK -4,255 compared with DKK -5,675 the year before. Equity in the 2024 report amounted to DKK 789,098.
